The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 348:2256-2257 May 29, 2003 Number 22
NextNext

Human Growth Hormone and Aging

 

This Article
- PDF
-PDA Full Text

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
 by Vance, M. L.
-PubMed Citation
To the Editor: Vance's discussion of growth hormone (Feb. 27 issue)1 omits important reports in the literature. The combination of growth hormone and exercise (unlike exercise alone) has been shown to increase type II muscle fibers in the elderly2 an important finding, since frailty and sarcopenia are predominantly related to the loss of type II fibers. There is no mention of the fact that decreased levels of insulin-like growth factor I have been reported to be associated with angina pectoris,3 myocardial infarction,4 and atherosclerosis,5 which are the leading causes of death in this country. The discussion also excludes a recent report that aging men with low levels of insulin-like growth factor I die earlier than those with high levels.6

Long-term prospective studies on the potential of growth hormone will take decades. In the meantime, the use of growth hormone should be based on a patient's clinical status and on a candid patient–physician discussion of current information on the pros and cons of such therapy.


Khalid Mahmud, M.D.
North Memorial Medical Center
Minneapolis, MN 55422
kmahmud{at}idinhealth.com

References

  1. Vance ML. Can growth hormone prevent aging? N Engl J Med 2003;348:779-780. [Free Full Text]
  2. Hennessey JV, Chromiak JA, DellaVentura S, et al. Growth hormone administration and exercise effects on muscle fiber type and diameter in moderately frail older people. J Am Geriatr Soc 2001;49:852-858. [CrossRef][Web of Science][Medline]
  3. Conti E, Andreotti F, Sestito A, et al. Reduced levels of insulin-like growth factor-1 in patients with angina pectoris, positive exercise stress test, and angiographically normal epicardial coronary arteries. Am J Cardiol 2002;89:973-975. [CrossRef][Web of Science][Medline]
  4. Conti E, Andreotti F, Sciahbasi A, et al. Markedly reduced insulin-like growth factor-1 in the acute phase of myocardial infarction. J Am Coll Cardiol 2001;38:26-32. [Free Full Text]
  5. van den Beld AW, Bots ML, Janssen JA, Pols HA, Lamberts SW, Grobbee DE. Endogenous hormones and carotid atherosclerosis in elderly men. Am J Epidemiol 2003;157:25-31. [Free Full Text]
  6. Ruiz-Torres A, Soares de Melo Kirzner M. Ageing and longevity are related to growth hormone/insulin like growth factor-1 secretion. Gerontology 2002;48:401-407. [CrossRef][Medline]

 
Dr. Vance replies: Dr. Mahmud correctly notes that the combination of growth hormone and exercise increases type II muscle fibers in the elderly. As stated in my Retrospective article, changes in body composition with growth hormone administration do not improve function in the elderly. Reduced levels of insulin-like growth factor I may be associated with other diseases, although such an association is not proof of cause and effect and may echo the effect of disease; for example, insulin-like growth factor I may be low in young women with anorexia nervosa.1 That older men with low levels of insulin-like growth factor I may die earlier than those with high levels may reflect underlying diseases. Rudman et al. reported that elderly men living independently had higher levels of insulin-like growth factor I than those living in a nursing home and had fewer medical problems.2 Again, these associations are valid but do not demonstrate cause and effect.

"Long-term prospective studies on the potential of growth hormone will take decades": I agree. Without such studies, anyone can easily fall prey to unproven claims. Recall laetrile for cancer: How many people "believed" that it was efficacious? How many did not receive appropriate therapies, in the quest for a "magic bullet"? Appropriate studies, not opinions, are the only way to determine whether a treatment is beneficial.


Mary Lee Vance, M.D.
University of Virginia Medical Center
Charlottesville, VA 22908
mlv{at}virginia.edu

Editor's note: Dr. Vance has reported receiving grant support and consulting fees from Pharmacia and grant support from Eli Lilly and Genentech.

References

  1. Caregaro L, Favaro A, Santonastaso P, et al. Insulin-like growth factor 1 (IGF-1), a nutritional marker in patients with eating disorders. Clin Nutr 2001;20:251-257. [CrossRef][Medline]
  2. Rudman D, Nagraj HS, Mattson DE, et al. Hyposomatomedinemia in the men of a Veterans Administration nursing home: prevalence and correlates. Gerontology 1987;33:307-314. [Medline]

 

This Article
- PDF
-PDA Full Text

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
 by Vance, M. L.
-PubMed Citation


HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.